Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Garceau

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Pharmacology|December 1, 1994
Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid componentsM Tanguay, G Lepage, G Blaise, et al.
Transplantation|July 1, 1993
Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantationL Dumont, H Chen, P Daloze, et al.
The Journal of Nutrition, Health & Aging|October 9, 2009
Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase StudyD Saumier, A Duong, D Haine, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1992
Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogsR Gaspo, L Lamarche, N Yamaguchi, et al.
Canadian Journal of Physiology and Pharmacology|April 1, 1991
Peripheral vasodilator and cardiac properties of the 1,5-benzothiazepine calcium antagonist analog, TA-3090, in dogsL Dumont, M Derouin, C Chartrand, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
High-performance liquid chromatographic method for the assay of TA-3090 and its pharmacokinetic parameters in healthy volunteersM Lefebvre, D Garceau, J Spenard, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1992
The effect of a new calcium channel blocker (TA-3090) on lipoprotein profile and intestinal lipid handling in rodentsE Levy, L Smith, L Dumont, et al.
Neurology|November 4, 2006
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer diseaseP S Aisen, D Saumier, R Briand, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2001
Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathyF Gervais, R Chalifour, D Garceau, et al.
Atherosclerosis|October 1, 1991
Effect of clentiazem on lipid profile, lipoprotein composition and aortic fatty streaks in cholesterol-fed rabbitsE Levy, J Tardif, P Russo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|December 1, 1994
Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid componentsM Tanguay, G Lepage, G Blaise, et al.
Transplantation|July 1, 1993
Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantationL Dumont, H Chen, P Daloze, et al.
The Journal of Nutrition, Health & Aging|October 9, 2009
Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase StudyD Saumier, A Duong, D Haine, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1992
Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogsR Gaspo, L Lamarche, N Yamaguchi, et al.
Canadian Journal of Physiology and Pharmacology|April 1, 1991
Peripheral vasodilator and cardiac properties of the 1,5-benzothiazepine calcium antagonist analog, TA-3090, in dogsL Dumont, M Derouin, C Chartrand, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 1, 1989
High-performance liquid chromatographic method for the assay of TA-3090 and its pharmacokinetic parameters in healthy volunteersM Lefebvre, D Garceau, J Spenard, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1992
The effect of a new calcium channel blocker (TA-3090) on lipoprotein profile and intestinal lipid handling in rodentsE Levy, L Smith, L Dumont, et al.
Neurology|November 4, 2006
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer diseaseP S Aisen, D Saumier, R Briand, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 26, 2001
Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathyF Gervais, R Chalifour, D Garceau, et al.
Atherosclerosis|October 1, 1991
Effect of clentiazem on lipid profile, lipoprotein composition and aortic fatty streaks in cholesterol-fed rabbitsE Levy, J Tardif, P Russo, et al.
Pageof 3